- Tytuł:
-
A proof of concept phase II study with the PDE-4 inhibitor roflumilast in patients with mild
cognitive impairment or mild Alzheimer's disease dementia (ROMEMA): study protocol of a double-blind, randomized, placebo-controlled, between-subjects trial. - Autorzy:
- Źródło:
- Trials [Trials] 2024 Mar 04; Vol. 25 (1), pp. 162. Date of Electronic Publication: 2024 Mar 04.
- Typ publikacji:
- Clinical Trial Protocol; Journal Article
- MeSH Terms:
-
Alzheimer Disease*/diagnosis
Alzheimer Disease*/drug therapy
Phosphodiesterase 4 Inhibitors*/adverse effects
Dementia*Cognitive Dysfunction */diagnosisCognitive Dysfunction */drug therapy
Aminopyridines*
Benzamides*
Adult ; Aged ; Humans ; Randomized Controlled Trials as Topic ; Clinical Trials, Phase II as Topic ; Cyclopropanes
Czasopismo naukowe